Poster Presentations 2017
DOI: 10.1136/annrheumdis-2017-eular.5052
View full text |Buy / Rent full text
|
Sign up to set email alerts
|

Abstract: BackgroundBiotherapies such as subcutaneous tumour necrosis factor-alpha inhibitors (SC-TNFis) have transformed the management of inflammatory joint diseases such as ankylosing spondylitis (AS). The assessment of SC- TNFis persistence and its determinants is needed.ObjectivesThe objective of this study was to describe treatment persistence in real-world settings, and identify the determinants of persistence among AS patients initiating treatment with an SC-TNFi.MethodsThe French national health insurance schem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
4
0
Order By: Relevance
“…Eight studies found females to be significantly less persistent 32 34 38–40 43 48 49. Biological-experienced patients were significantly less persistent in six studies38–40 45 46 52 while four studies found no difference between biological-naïve and biological-experienced patients 34 35 46 51. ‘No concomitant DMARDs’ were found to be a predictor of low persistence in three studies 32 43 48.…”
Section: Resultsmentioning
confidence: 91%
“…One study reported exclusively on an AS population38; five reported exclusively on a PsA population27 39 43 50 52 and six studies reported exclusively on an RA population 28 31 34 40 41 46. Fourteen studies29 30 32 33 35–37 42 44 45 47–49 52 included at least two different IMRD patient populations, and one study53 did not provide any data on disease distribution within the cohort.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations